A carregar...

A Phase I Combination Study of Trabectedin and Doxorubicin in Patients With Soft Tissue Sarcoma

PURPOSE: To determine the dose of trabectedin plus doxorubicin with granulocyte colony stimulating factor (G-CSF) support associated with manageable neutropenia and acceptable dose-limiting toxicities (DLTs) in patients with recurrent or persistent soft tissue sarcoma (STS). METHODS: In this phase I...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Blay, Jean-Yves, Mehren, Margaret von, Samuels, Brian L., Fanucchi, Michael P., Ray-Coquard, Isabelle, Buckley, Brigid, Gilles, Leen, Lebedinsky, Claudia, Elsayed, Yusri A., Cesne, Axel Le
Formato: Artigo
Idioma:Inglês
Publicado em: 2008
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2777645/
https://ncbi.nlm.nih.gov/pubmed/18927308
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-08-0336
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!